Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months-Reference-Cited by-同舟云学术

Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months

Published:2021-07 Issue:32 Volume:39 Page:4545-4554
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Østergaard Lars,Vesikari Timo,Senders Shelly D.,Flodmark Carl-Erik^ORCID,Kosina Pavel,Jiang Han-Qing,Maguire Jason D.,Absalon Judith,Jansen Kathrin U.,Harris Shannon L.^ORCID,Maansson Roger,Balmer Paul,Beeslaar Johannes,Perez John L.

Funder

Pfizer

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference31 articles.

1. Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013;62:1-28. https://dx.doi.org/rr6202a1 [pii].

2. Global epidemiology of invasive meningococcal disease;Jafri;Popul Health Metr,2013

3. Centers for Disease Control. Enhanced meningococcal disease surveillance report, 2017, https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report-2017.pdf; 2017 [accessed May 10, 2019].

4. European Centre for Disease Prevention and Control. Annual epidemiological report for 2017 invasive meningococcal disease, https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2017-invasive-meningococcal-disease.pdf; 2019 [accessed April 24, 2019].

5. University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013–2018;Soeters;Emerg Infect Dis,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Policies for the immunization against serogroup B meningococcus for adolescents immunized during the first two years of life: A mini review;Human Vaccines & Immunotherapeutics;2024-09-12

2. Meningokokkenimpfung;Monatsschrift Kinderheilkunde;2024-04-08

3. The important lessons lurking in the history of meningococcal epidemiology;Expert Review of Vaccines;2024-04-04

4. Epidemiology of Meningococcal Disease in Four South American Countries and Rationale of Vaccination in Adolescents from the Region: Position Paper of the Latin American Society of Pediatric Infectious Diseases (SLIPE);Vaccines;2023-12-12

5. Was gibt es Neues bei der Meningokokken- und Pneumokokken-Impfung?;Kinder- und Jugendmedizin;2023-06